ENST00000474784.5:n.239+220G>C

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The ENST00000474784.5(GPLD1):​n.239+220G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.327 in 361,032 control chromosomes in the GnomAD database, including 20,384 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.34 ( 8971 hom., cov: 32)
Exomes 𝑓: 0.32 ( 11413 hom. )

Consequence

GPLD1
ENST00000474784.5 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.140

Publications

7 publications found
Variant links:
Genes affected
GPLD1 (HGNC:4459): (glycosylphosphatidylinositol specific phospholipase D1) Many proteins are tethered to the extracellular face of eukaryotic plasma membranes by a glycosylphosphatidylinositol (GPI) anchor. The GPI-anchor is a glycolipid found on many blood cells. The protein encoded by this gene is a GPI degrading enzyme. Glycosylphosphatidylinositol specific phospholipase D1 hydrolyzes the inositol phosphate linkage in proteins anchored by phosphatidylinositol glycans, thereby releasing the attached protein from the plasma membrane. [provided by RefSeq, Jul 2008]
ALDH5A1 (HGNC:408): (aldehyde dehydrogenase 5 family member A1) This protein belongs to the aldehyde dehydrogenase family of proteins. This gene encodes a mitochondrial NAD(+)-dependent succinic semialdehyde dehydrogenase. A deficiency of this enzyme, known as 4-hydroxybutyricaciduria, is a rare inborn error in the metabolism of the neurotransmitter 4-aminobutyric acid (GABA). In response to the defect, physiologic fluids from patients accumulate GHB, a compound with numerous neuromodulatory properties. Two transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Jul 2008]
ALDH5A1 Gene-Disease associations (from GenCC):
  • succinic semialdehyde dehydrogenase deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, ClinGen, Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.76).
BP6
Variant 6-24494747-C-G is Benign according to our data. Variant chr6-24494747-C-G is described in ClinVar as Benign. ClinVar VariationId is 1281626.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.375 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ALDH5A1NM_001080.3 linkc.-250C>G upstream_gene_variant ENST00000357578.8 NP_001071.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ALDH5A1ENST00000357578.8 linkc.-250C>G upstream_gene_variant 1 NM_001080.3 ENSP00000350191.3

Frequencies

GnomAD3 genomes
AF:
0.337
AC:
51137
AN:
151964
Hom.:
8957
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.380
Gnomad AMI
AF:
0.422
Gnomad AMR
AF:
0.232
Gnomad ASJ
AF:
0.293
Gnomad EAS
AF:
0.192
Gnomad SAS
AF:
0.286
Gnomad FIN
AF:
0.332
Gnomad MID
AF:
0.271
Gnomad NFE
AF:
0.351
Gnomad OTH
AF:
0.308
GnomAD4 exome
AF:
0.320
AC:
66930
AN:
208952
Hom.:
11413
AF XY:
0.319
AC XY:
33794
AN XY:
105792
show subpopulations
African (AFR)
AF:
0.370
AC:
2154
AN:
5826
American (AMR)
AF:
0.227
AC:
1297
AN:
5722
Ashkenazi Jewish (ASJ)
AF:
0.277
AC:
2059
AN:
7440
East Asian (EAS)
AF:
0.190
AC:
3508
AN:
18426
South Asian (SAS)
AF:
0.281
AC:
575
AN:
2048
European-Finnish (FIN)
AF:
0.329
AC:
5503
AN:
16744
Middle Eastern (MID)
AF:
0.222
AC:
242
AN:
1088
European-Non Finnish (NFE)
AF:
0.342
AC:
47270
AN:
138158
Other (OTH)
AF:
0.320
AC:
4322
AN:
13500
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
2096
4192
6289
8385
10481
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
400
800
1200
1600
2000
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.337
AC:
51200
AN:
152080
Hom.:
8971
Cov.:
32
AF XY:
0.329
AC XY:
24487
AN XY:
74352
show subpopulations
African (AFR)
AF:
0.380
AC:
15767
AN:
41500
American (AMR)
AF:
0.232
AC:
3544
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.293
AC:
1016
AN:
3468
East Asian (EAS)
AF:
0.192
AC:
993
AN:
5162
South Asian (SAS)
AF:
0.285
AC:
1377
AN:
4830
European-Finnish (FIN)
AF:
0.332
AC:
3508
AN:
10582
Middle Eastern (MID)
AF:
0.274
AC:
80
AN:
292
European-Non Finnish (NFE)
AF:
0.351
AC:
23874
AN:
67942
Other (OTH)
AF:
0.311
AC:
657
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1713
3426
5140
6853
8566
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
506
1012
1518
2024
2530
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.352
Hom.:
1169
Bravo
AF:
0.332
Asia WGS
AF:
0.255
AC:
891
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
Jul 15, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.76
CADD
Benign
6.2
DANN
Benign
0.74
PhyloP100
-0.14
PromoterAI
-0.099
Neutral

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2744575; hg19: chr6-24494975; API